68Ga-DOTATOC PET/CT and somatostatin receptor (sst1-sst5) expression in normal human tissue: correlation of sst2 mRNA and SUVmax
- PMID: 21369945
- DOI: 10.1007/s00259-011-1760-x
68Ga-DOTATOC PET/CT and somatostatin receptor (sst1-sst5) expression in normal human tissue: correlation of sst2 mRNA and SUVmax
Abstract
Purpose: By targeting somatostatin receptors (sst) radiopeptides have been established for both diagnosis and therapy. For physiologically normal human tissues the study provides a normative database of maximum standardized uptake value (SUV(max)) and sst mRNA.
Methods: A total of 120 patients were subjected to diagnostic (68)Ga-DOTATOC positron emission tomography (PET)/CT (age range 19-83 years). SUV(max) values were measured in physiologically normal tissues defined by normal morphology, absence of surgical intervention and absence of metastatic spread during clinical follow-up. Expression of sst subtypes (sst1-sst5) was measured independently in pooled adult normal human tissue by real-time reverse transcriptase polymerase chain reaction (RT-PCR).
Results: SUV(max) revealed a region-specific pattern (e.g., mean ± SD, spleen 31.1 ± 10.9, kidney 16.9 ± 5.3, liver 12.8 ± 3.6, stomach 7.0 ± 3.1, head of pancreas 6.2 ± 2.3, small bowel 4.8 ± 1.8, thyroid 4.7 ± 2.2, bone 3.9 ± 1.3, large bowel 2.9 ± 0.8, muscle 2.1 ± 0.5, parotid gland 1.9 ± 0.6, axillary lymph node 0.8 ± 0.3 and lung 0.7 ± 0.3). SUV(max) was age independent. Gender differences were evident within the thyroid (female/male: 3.7 ± 1.6/5.5 ± 2.4, p < 0.001; Mann-Whitney U test) and the pancreatic head (5.5 ± 1.9/6.9 ± 2.2, p < 0.001). The sst mRNA was widely expressed and heterogeneous, showing sst1 to be most abundant. SUV(max) values exclusively correlated with sst2 expression (r = 0.846, p < 0.001; Spearman rank correlation analysis), whereas there was no correlation of SUV(max) with the expression of the other four subtypes.
Conclusion: In normal human tissues (68)Ga-DOTATOC imaging has been related to the expression of sst2 at the level of mRNA. The novel normative database may improve diagnostics, monitoring and therapy of sst-expressing tumours or inflammation on a molecular basis.
Similar articles
-
Association of somatostatin receptor 2 immunohistochemical expression with [111In]-DTPA octreotide scintigraphy and [68Ga]-DOTATOC PET/CT in neuroendocrine tumors.Horm Metab Res. 2010 Jul;42(8):599-606. doi: 10.1055/s-0030-1253354. Epub 2010 Apr 26. Horm Metab Res. 2010. PMID: 20422506
-
Differential uptake of (68)Ga-DOTATOC and (68)Ga-DOTATATE in PET/CT of gastroenteropancreatic neuroendocrine tumors.Recent Results Cancer Res. 2013;194:353-71. doi: 10.1007/978-3-642-27994-2_18. Recent Results Cancer Res. 2013. PMID: 22918768
-
Focal uptake of 68Ga-DOTATOC in the pancreas: pathological or physiological correlate in patients with neuroendocrine tumours?Eur J Nucl Med Mol Imaging. 2011 Nov;38(11):2005-13. doi: 10.1007/s00259-011-1875-0. Epub 2011 Jul 27. Eur J Nucl Med Mol Imaging. 2011. PMID: 21792572
-
Current knowledge on the sensitivity of the (68)Ga-somatostatin receptor positron emission tomography and the SUVmax reference range for management of pancreatic neuroendocrine tumours.Eur J Nucl Med Mol Imaging. 2016 Oct;43(11):2072-83. doi: 10.1007/s00259-016-3395-4. Epub 2016 May 13. Eur J Nucl Med Mol Imaging. 2016. PMID: 27174220 Free PMC article. Review.
-
Binding properties of somatostatin receptor subtypes.Metabolism. 1996 Aug;45(8 Suppl 1):17-20. doi: 10.1016/s0026-0495(96)90072-4. Metabolism. 1996. PMID: 8769372 Review.
Cited by
-
Phase I study of the 177Lu-DOTA0-Tyr3-Octreotate (lutathera) in combination with nivolumab in patients with neuroendocrine tumors of the lung.J Immunother Cancer. 2020 Jul;8(2):e000980. doi: 10.1136/jitc-2020-000980. J Immunother Cancer. 2020. PMID: 32616557 Free PMC article. Clinical Trial.
-
Thyroid gland changes in patients with acromegaly.Arch Endocrinol Metab. 2020 May-Jun;64(3):269-275. doi: 10.20945/2359-3997000000247. Arch Endocrinol Metab. 2020. PMID: 32555993 Free PMC article.
-
Semiquantitative evaluation of 68Ga-DOTANOC uptake in the normal myocardium: establishment of reference values.J Nucl Cardiol. 2023 Jun;30(3):1121-1128. doi: 10.1007/s12350-022-03135-w. Epub 2022 Nov 23. J Nucl Cardiol. 2023. PMID: 36417120
-
PET/CT imaging of neuroendocrine tumors with (68)Gallium-labeled somatostatin analogues: An overview and single institutional experience from India.Indian J Nucl Med. 2014 Jan;29(1):2-12. doi: 10.4103/0972-3919.125760. Indian J Nucl Med. 2014. PMID: 24591775 Free PMC article. Review.
-
The tumour sink effect on the biodistribution of 68Ga-DOTA-octreotate: implications for peptide receptor radionuclide therapy.Eur J Nucl Med Mol Imaging. 2012 Jan;39(1):50-6. doi: 10.1007/s00259-011-1937-3. Epub 2011 Sep 20. Eur J Nucl Med Mol Imaging. 2012. PMID: 21932117